Scarica l'app Stockscreener
12.16
1.16%
0.14
Dopo l'orario di chiusura:
12.16
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVTR Giù?
Forum
Previsione
Precedente Chiudi:
$12.02
Aprire:
$11.98
Volume 24 ore:
9.16M
Relative Volume:
0.88
Capitalizzazione di mercato:
$8.29B
Reddito:
$6.82B
Utile/perdita netta:
$309.60M
Rapporto P/E:
27.02
EPS:
0.45
Flusso di cassa netto:
$747.20M
1 W Prestazione:
-2.01%
1M Prestazione:
+8.57%
6M Prestazione:
-5.44%
1 anno Prestazione:
-46.12%
Intervallo 1D:
$11.87
$12.21
Intervallo di 1 settimana:
$11.78
$12.90
Portata 52W:
$10.62
$23.32
Avantor Inc Stock (AVTR) Company Profile
Nome
Avantor Inc
Settore
Industria
Telefono
(610) 386-1700
Indirizzo
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Confronta AVTR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVTR
Avantor Inc
|
12.16 | 8.20B | 6.82B | 309.60M | 747.20M | 0.45 |
|
ISRG
Intuitive Surgical Inc
|
535.00 | 191.90B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
207.11 | 59.36B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.00 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
257.58 | 38.05B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.12 | 33.62B | 27.43B | 1.27B | 1.01B | 1.5829 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-05 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-12-17 | Downgrade | Jefferies | Hold → Underperform |
| 2025-12-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-11-04 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2025-10-30 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-10-30 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-08-01 | Downgrade | Jefferies | Buy → Hold |
| 2025-04-29 | Downgrade | Goldman | Buy → Neutral |
| 2025-04-28 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-04-28 | Downgrade | Stifel | Buy → Hold |
| 2025-04-28 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-17 | Downgrade | UBS | Buy → Neutral |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-07-10 | Downgrade | Citigroup | Buy → Neutral |
| 2024-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-12-11 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-07-31 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-06-21 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-10-05 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-09-14 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-09-09 | Downgrade | Cleveland Research | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-04 | Downgrade | Citigroup | Buy → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-30 | Ripresa | Raymond James | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-08-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-06-04 | Iniziato | Goldman | Buy |
| 2021-04-29 | Aggiornamento | Stifel | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-08-02 | Iniziato | Cleveland Research | Neutral |
| 2019-06-14 | Iniziato | Janney | Buy |
| 2019-06-12 | Iniziato | Raymond James | Outperform |
| 2019-06-11 | Iniziato | Goldman | Buy |
| 2019-06-11 | Iniziato | Guggenheim | Buy |
| 2019-06-11 | Iniziato | JP Morgan | Overweight |
| 2019-06-11 | Iniziato | Jefferies | Buy |
| 2019-06-11 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-06-11 | Iniziato | Piper Jaffray | Neutral |
| 2019-06-11 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-06-11 | Iniziato | Robert W. Baird | Outperform |
| 2019-06-11 | Iniziato | SunTrust | Buy |
| 2019-06-11 | Iniziato | UBS | Buy |
| 2019-06-11 | Iniziato | William Blair | Outperform |
Mostra tutto
Avantor Inc Borsa (AVTR) Ultime notizie
Aug Intraday: Is Avantor Inc benefiting from interest rate changes2025 Major Catalysts & Daily Oversold Bounce Ideas - baoquankhu1.vn
Sentiment Review: Is Avantor Inc benefiting from interest rate changesPortfolio Risk Report & Stock Market Timing Techniques - baoquankhu1.vn
Investors in Avantor (NYSE:AVTR) Have Unfortunately Lost 60% Over the Last Five Years - 富途牛牛
SG Americas Securities LLC Boosts Holdings in Avantor, Inc. $AVTR - MarketBeat
Avantor and p-Chip Partner to Create Smart Labware With Built-In Digital IDs - MSN
Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm - TMX Newsfile
Pacific Capital Partners Ltd Trims Position in Avantor, Inc. $AVTR - MarketBeat
Avantor, Inc. $AVTR Shares Sold by Robeco Schweiz AG - MarketBeat
P-Chip Corporation, Choice One Rx, and RxERP Launch Precedent-Setting Trial Demonstrating Digital Traceability of Drug Supply Chains and Chain-of-Identity for DSCSA Compliance, Co-Sponsored by Avantor - marketscreener.com
Update Recap: How Avantor Inc stock reacts to bond yieldsQuarterly Profit Report & Community Verified Trade Signals - Bộ Nội Vụ
Does Avantor Inc stock trade at a discount to peersWeekly Investment Recap & Low Risk Entry Point Tips - Bộ Nội Vụ
p-Chip Corporation, Choice One Rx, and RxERP Launch Precedent-Setting Trial Demonstrating Digital Traceability of Drug Supply Chains and Chain-of-Identity for DSCSA Compliance, Co-Sponsored by Avantor - Yahoo Finance
Dividend Watch: Is now the right time to enter Avantor IncMarket Trend Review & Proven Capital Preservation Tips - baoquankhu1.vn
Avantor to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026 - Finviz
Avantor® to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026 - BioSpace
What does Wall Street think about Avantor, Inc. (AVTR)? - MSN
Avantor, Inc. $AVTR Shares Purchased by Robeco Institutional Asset Management B.V. - MarketBeat
KLP Kapitalforvaltning AS Has $1.78 Million Holdings in Avantor, Inc. $AVTR - MarketBeat
Avantor, Inc. (AVTR) Stock Analysis: Navigating a 5.04% Potential Upside Amidst Healthcare Sector Challenges - DirectorsTalk Interviews
Peregrine Capital Management LLC Trims Stake in Avantor, Inc. $AVTR - MarketBeat
Avantor’s JPMorgan Spotlight Puts Its Science Supply Empire on Center Stage - MyChesCo
Here's why you should hold Avantor stock in your portfolio for now - MSN
Can Avantor Inc. stock sustain margin levelsJuly 2025 Sentiment & High Conviction Investment Ideas - Улправда
Can Avantor Inc. stock maintain operating marginsWeekly Trade Report & Fast Gain Swing Trade Alerts - Улправда
Growth Recap: Can Avantor Inc. stock beat market expectations this quarterJuly 2025 Decliners & Capital Efficiency Focused Strategies - ulpravda.ru
Avantor Posts $712 Million Loss Amid Goodwill Charge, Launches $500M Buyback - MSN
Aug Analyst Calls: Why Avantor Inc. stock attracts global investors2025 Breakouts & Breakdowns & High Conviction Buy Zone Picks - Улправда
Why Avantor Inc. stock attracts global investorsJuly 2025 Price Swings & Weekly High Return Stock Opportunities - ulpravda.ru
Can Avantor Inc. stock deliver strong Q4 earnings2025 Macro Impact & Low Volatility Stock Recommendations - ulpravda.ru
Will Avantor Inc. (AVG) stock sustain dividend payouts2025 Key Highlights & Risk Adjusted Swing Trade Ideas - ulpravda.ru
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now - Finviz
Will Avantor Inc. stock pay special dividendsTechnical Pattern Recognition & Interactive Charts for Smarter Trading - ulpravda.ru
Beyond The Numbers: 8 Analysts Discuss Avantor Stock - Benzinga
Avantor (NYSE:AVTR) Price Target Cut to $12.00 by Analysts at TD Cowen - MarketBeat
Should I buy Avantor Inc. (AVG) stock before earnings seasonMoving Average Strategies & Invest Smarter With Signals - ulpravda.ru
Avantor Stock Down 46% This Past Year, but One Fund's $23 Million Bet Signals Turnaround Potential - AOL.com
Avantor Unveils Next-Gen Bioprocessing Tools to Boost Efficiency and Safety - MSN
Is Avantor (AVTR) Now Fairly Priced After Years Of Share Price Weakness? - Yahoo Finance
Avantor® to Participate in 44th Annual J.P. Morgan Healthcare Co - GuruFocus
Avantor to Participate in 44th Annual J.P. Morgan Healthcare Conference - Finviz
Avantor® to Participate in 44th Annual J.P. Morgan Healthcare Conference - Chartmill
Avantor, Inc. (NYSE:AVTR) Given Consensus Recommendation of “Hold” by Analysts - Defense World
96,800 Shares in Avantor, Inc. $AVTR Bought by VIRGINIA RETIREMENT SYSTEMS ET Al - MarketBeat
Olstein Capital Management L.P. Acquires 115,000 Shares of Avantor, Inc. $AVTR - MarketBeat
Avantor Stock Down 46% This Past Year, but One Fund's $23 Million Bet Signals Turnaround Potential - The Motley Fool
What Does Wall Street Think About Avantor, Inc. (AVTR)? - Insider Monkey
Sectors Review: Is Avantor Inc AVG stock a top pick for value investorsQuarterly Market Summary & Reliable Price Breakout Alerts - moha.gov.vn
Avantor (NYSE:AVTR) Upgraded at Zacks Research - Defense World
3 Reasons to Avoid AVTR and 1 Stock to Buy Instead - Finviz
Contrasting Avantor (NYSE:AVTR) & BG Medicine (OTCMKTS:BGMD) - Defense World
Avantor (NYSE:AVTR) Raised to Hold at Zacks Research - MarketBeat
Avantor Inc Azioni (AVTR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.01%
1.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):